Lv6
2890 积分 2023-06-09 加入
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
2个月前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
2个月前
已完结
Extended characterization of anti-CD19 CAR T cell products manufactured at the point of care using the CliniMACS Prodigy system: comparison of donor sources and process duration
2个月前
已完结
Long-term remission and survival in patients with relapsed or refractory multiple myeloma after treatment with LCAR-B38M CAR T cells: 5-year follow-up of the LEGEND-2 trial
2个月前
已完结
Chimeric Antigen Receptor T-Cell and Bispecific Antibody Therapy in Multiple Myeloma: Moving Into the Future
2个月前
已完结
Phase II, Open-Label Study of Ciltacabtagene Autoleucel, an Anti–B-Cell Maturation Antigen Chimeric Antigen Receptor–T-Cell Therapy, in Chinese Patients With Relapsed/Refractory Multiple Myeloma (CARTIFAN-1)
2个月前
已完结
Acute lymphoblastic leukaemia
3个月前
已完结
皖公网安备34019202002308
